Development of a new drug for the treatment of Hepatitis B virus

| Hepatitis B | News | Treatments

Development of a new drug for the treatment of Hepatitis B virus

Hepalatide, used with pegylated interferon-alpha, shows promise for curing chronic hepatitis B by eliminating cccDNA from liver cells, according to early study results presented in a European liver congress.

| Hepatitis B | News | Treatments

Efficacy of a new treatment for hepatitis B

A new treatment for chronic hepatitis B using an antisense probe shows promising results, with 62% achieving theoretical cure and mild side effects.

| Hepatitis B | News | Treatments

Withdrawal of antiviral treatment in Hepatitis B

Chronic hepatitis B affects over 250 million people worldwide and can progress to cirrhosis and liver cancer.

| Fatty liver | Hepatitis | Hepatitis B

The impact of fatty liver in chronic hepatitis b

Fatty liver is one of the most frequent diseases and affects 25-30% of the world population.

| Hepatitis B | News | Treatments

New treatment for Chronic Hepatitis B

Chronic hepatitis B virus infection is a global health problem.

| Diseases | Hepatitis B

New treatment for Hepatitis B with vaccine

New trials published with hepatitis B patients suggests the use of liposome nanoparticles with virus antigens for their treatment.